ST-36

N/A

Report date: 2024/12/03 10:25:34
NME

Base Information

Drug NameST-36
Drug Alias NameST-36
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionCyclic AMP-dependent transcription factor ATF-5 inhibitors
TargetsCyclic AMP-dependent transcription factor ATF-5
Therapy Area/IndicationsNeuroblastomaGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesColumbia University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSapience Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsNeuroblastomaGlioblastoma

Other Information

ATC CodeN/A
Related LinksN/A